Propranolol given orally for proliferating infantile haemangiomas: Analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients

British Journal of Oral and Maxillofacial Surgery

Volumn 51, Issue 7, 2013, Pages 656-661

  Yuan, Wei Li ^a   Jin, Zhi Lei ^a   Wei, Jing Jian ^a   Liu, Zheng Yu ^a   Xue, Lei ^a   Wang, Xu Kai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

eNOS; Proliferating infantile haemangioma; Propranolol; Serum; VEGF

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROPRANOLOL; VASCULOTROPIN;

ANOREXIA; ARTICLE; BRADYCARDIA; BREATHING RATE; CAPILLARY HEMANGIOMA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; INFANT; MALE; PROTEIN BLOOD LEVEL; SEROLOGY; SIDE EFFECT;

ENOS; PROLIFERATING INFANTILE HAEMANGIOMA; PROPRANOLOL; SERUM; VEGF;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; MALE; NITRIC OXIDE SYNTHASE; PROPRANOLOL; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883781610     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2012.12.003     Document Type: Article

References (25)

1. D. Metry Update on hemangiomas of infancy Curr Opin Pediatr 16 2004 373 377
2. M.L. Bennett, A.B. Fleischer Jr., and S.L. Chamlin Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation Arch Dermatol 137 2001 1208 1213
3. A.L. Bruckner, and I.J. Frieden Hemangiomas of infancy J Am Acad Dermatol 48 2003 477 493
4. A.P. Michaud, N.M. Bauman, and D.K. Burke Spastic diplegia and other motor disturbances in infants receiving interferon-alpha Laryngoscope 114 2004 1231 1236
5. C. Léauté-Labrèze, E. Dumas de la Roque, and T. Hubiche Propranolol for severe hemangiomas of infancy N Engl J Med 358 2008 2649 2651
6. M. Waner, and J.Y. Suen Hemangiomas and vascular malformations of the head and neck vol. 3 1999 Wiley-Liss Inc. New York p. 57-8, 93-169
7. W.J. Holmes, A. Mishra, and C. Gorst Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas J Plast Reconstr Aesthet Surg 64 2011 445 451
8. A.N. Haggstrom, B.A. Drolet, and E. Baselga Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment Pediatrics 118 2006 882 887
9. B.M. Achauer, C.J. Chang, and V.M. Vander Kam Management of hemangioma of infancy: review of 245 patients Plast Reconstr Surg 99 1997 1301 1308
10. Z.P. Qin, X.J. Liu, and K.L. Li Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety Zhonghua Yi Xue Za Zhi 89 2009 3130 3134 [in Chinese]
11. M. Naouri, T. Schill, and A. Maruani Successful treatment of ulcerated haemangioma with propranolol J Eur Acad Dermatol Venereol 24 2010 1109 1112
12. A. Zvulunov, C. McCuaig, and I.J. Frieden Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study Pediatr Dermatol 28 2011 94 98
13. L.M. Buckmiller, P.D. Munson, and U. Dyamenahalli Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center Laryngoscope 120 2010 676 681
14. M. Artman, M. Grayson, and R.C. Boerth Propranolol in children: safety-toxicity Pediatrics 70 1982 30 31
15. L. Li, and L. Ma Efficacy and adverse effects of propranolol in the treatment of severe hemangiomas in infancy Int J Dermatol Venereol 6 2010 325 327
16. C.H. Storch, and P.H. Hoeger Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action Br J Dermatol 163 2010 269 274
17. D. Ribatti The crucial role of vascular permeability factor/vascular endothelial factor in angiogenesis: a historical review Br J Haematol 128 2005 303 309
18. J.S. Frischer, J. Huang, and A. Serur Biomolecular markers and involution of hemangiomas J Pediatr Surg 39 2004 400 404
19. L. Zhang, X. Lin, and W. Wang Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients Plast Reconstr Surg 116 2005 200 204
20. E.V. Yang, A.K. Sood, and M. Chen Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells Cancer Res 66 2006 10357 10364
21. H.A. Al-Wadei, M.H. Al-Wadei, and H.M. Schuller Prevention of pancreatic cancer by the beta-blocker propranolol Anticancer Drugs 20 2009 477 482
22. M. Ziche, L. Morbidelli, and E. Masini Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P J Clin Invest 94 1994 2036 2044
23. S.S. Lei, Y.T. Tu, and X.Q. Zhu Expression of nitric oxide synthase and vascular endothelial growth factor in hemangioma and its relation to angiogenesis Zhong Guo PiFu Xing Bing Xue Za Zhi 10 2007 580 582 [in Chinese]
24. T.C. Westfall, and D.P. Westfall Neurotransmission: the autonomic and somatic motor nervous systems L.L. Brunton, J.S. Lazo, K.L. Parker, Goodman & Gilman's the pharmacological basis of therapeutics 11th ed. 2006 McGraw-Hill New York 167
25. T.C. Westfall, and D.P. Westfall Adrenergic agonists and antagonists L.L. Brunton, J.S. Lazo, K.L. Parker, Goodman & Gilman's the pharmacological basis of therapeutics 11th ed. 2006 McGraw-Hill New York 271 295